Sanofi to launch Enzymatica’s product in Turkey
Premium
5 April 2022
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, in Turkey.
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
5 April 2022
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, in Turkey.
14 March 2022
Sanofi Consumer Healthcare has extended its licensing deal for Enzymatica’s mouth spray against the common to include Mexico as well as France and Italy.
9 September 2021
Enzymatica’s new chief executive has taken office ahead of schedule, Plexus Ventures has promoted Gabriele Tundo, and Lonza has a new chief financial officer.
23 July 2021
Karo Pharma, Probi and Enzymatica have released financial results.
13 July 2021
Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect in Vietnam and plans to launch the common cold spray in the country in 2022.
13 July 2021
Enzymatica – the Swedish company behind the ColdZyme common cold spray – has promoted Claus Egstrand to chief executive officer.
22 June 2021
Enzymatica has recruited two people, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed a new presidency team, and the US Consumer Healthcare Products Association (CHPA) has honoured a longtime industry leader.
7 June 2021
Enzymatica has started selling its ColdZyme common cold spray on Amazon in Sweden and the UK.
29 March 2021
Enzymatica has warned that sales of its ColdZyme common cold spray may be lower in 2021 than in 2020 due to the impact of the COVID-19 pandemic.
19 January 2021
McKesson Europe has a new chief financial officer, Sweden’s Enzymatica has made changes to its management team, and the US Council for Responsible Nutrition (CRN) has a new chair.